BIOHAVEN ($BHVN) posted quarterly earnings results for Q2 2026 on Monday, August 10th. The company reported earnings of -$0.91 per share, missing estimates of -$0.75 by $0.16. The company also reported revenue of $0, missing estimates of $546,169 by $-546,169.
Stock price change since market close: -3.99%
You can see Quiver Quantitative's $BHVN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
EARLY ACCESS
Receive BHVN Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →
BIOHAVEN Hedge Fund Activity
We have seen 159 institutional investors add shares of BIOHAVEN stock to their portfolio, and 98 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 1,988,178 shares (+17.7%) to their portfolio in Q2 2026, for an estimated $29,584,088
- CORMORANT ASSET MANAGEMENT, LP added 1,750,000 shares (+17500.0%) to their portfolio in Q1 2026, for an estimated $14,629,999
- SCHONFELD STRATEGIC ADVISORS LLC removed 1,606,777 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $13,432,655
- BANK OF AMERICA CORP /DE/ removed 1,033,018 shares (-57.6%) from their portfolio in Q1 2026, for an estimated $8,636,030
- BALYASNY ASSET MANAGEMENT L.P. added 854,362 shares (+53.7%) to their portfolio in Q1 2026, for an estimated $7,142,466
- AMERICAN CENTURY COMPANIES INC removed 674,216 shares (-98.3%) from their portfolio in Q1 2026, for an estimated $5,636,445
- JANE STREET GROUP, LLC removed 611,073 shares (-72.8%) from their portfolio in Q1 2026, for an estimated $5,108,570
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
BIOHAVEN Price Targets
Multiple analysts have issued price targets for $BHVN recently. We have seen 6 analysts offer price targets for $BHVN in the last 6 months, with a median target of $17.5.
Here are some recent targets:
- Jason Gerberry from B of A Securities set a target price of $11.0 on 06/29/2026
- Douglas Tsao from HC Wainwright & Co. set a target price of $10.0 on 05/26/2026
- Terence Flynn from Morgan Stanley set a target price of $18.0 on 05/13/2026
- Leonid Timashev from RBC Capital set a target price of $22.0 on 05/05/2026
- Samantha Semenkow from Citigroup set a target price of $17.0 on 04/02/2026
- Tyler Van Buren from TD Cowen set a target price of $30.0 on 03/11/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
Read full article here »
BIOHAVEN ($BHVN) Releases Q2 2026 Earnings
BIOHAVEN ($BHVN) posted quarterly earnings results for Q2 2026 on Monday, August 10th. The company reported earnings of -$0.91 per share, missing estimates of -$0.75 by $0.16. The company also reported revenue of $0, missing estimates of $546,169 by $-546,169.
Stock price change since market close: -3.99%
You can see Quiver Quantitative's $BHVN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIOHAVEN Hedge Fund Activity
We have seen 159 institutional investors add shares of BIOHAVEN stock to their portfolio, and 98 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
BIOHAVEN Price Targets
Multiple analysts have issued price targets for $BHVN recently. We have seen 6 analysts offer price targets for $BHVN in the last 6 months, with a median target of $17.5.
Here are some recent targets:
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
Read full article here »